Cargando…

Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center

Objective: to evaluate the efficacy of US, both qualitatively and semi-quantitatively, in the selection of treatment for the Covid-19 patient, using patient triage as the gold standard. Methods: Patients admitted to the Covid-19 clinic to be treated with monoclonal antibodies (mAb) or retroviral tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Vincenza, Fusco, Roberta, Villanacci, Alberta, Grassi, Francesca, Grassi, Roberta, Di Stefano, Federica, Petrone, Ada, Fusco, Nicoletta, Ianniello, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220348/
https://www.ncbi.nlm.nih.gov/pubmed/37245026
http://dx.doi.org/10.1186/s13027-023-00515-w
_version_ 1785049200052928512
author Granata, Vincenza
Fusco, Roberta
Villanacci, Alberta
Grassi, Francesca
Grassi, Roberta
Di Stefano, Federica
Petrone, Ada
Fusco, Nicoletta
Ianniello, Stefania
author_facet Granata, Vincenza
Fusco, Roberta
Villanacci, Alberta
Grassi, Francesca
Grassi, Roberta
Di Stefano, Federica
Petrone, Ada
Fusco, Nicoletta
Ianniello, Stefania
author_sort Granata, Vincenza
collection PubMed
description Objective: to evaluate the efficacy of US, both qualitatively and semi-quantitatively, in the selection of treatment for the Covid-19 patient, using patient triage as the gold standard. Methods: Patients admitted to the Covid-19 clinic to be treated with monoclonal antibodies (mAb) or retroviral treatment and undergoing lung ultrasound (US) were selected from the radiological data set between December 2021 and May 2022 according to the following inclusion criteria: patients with proven Omicron variant and Delta Covid-19 infection; patients with known Covid-19 vaccination with at least two doses. Lung US (LUS) was performed by experienced radiologists. The presence, location, and distribution of abnormalities, such as B-lines, thickening or ruptures of the pleural line, consolidations, and air bronchograms, were evaluated. The anomalous findings in each scan were classified according to the LUS scoring system. Nonparametric statistical tests were performed. Results: The LUS score median value in the patients with Omicron variant was 1.5 (1–20) while the LUS score median value in the patients with Delta variant was 7 (3–24). A difference statistically significant was observed for LUS score values among the patients with Delta variant between the two US examinations (p value = 0.045 at Kruskal Wallis test). There was a difference in median LUS score values between hospitalized and non-hospitalized patients for both the Omicron and Delta groups (p value = 0.02 on the Kruskal Wallis test). For Delta patients groups the sensitivity, specificity, positive and negative predictive values, considering a value of 14 for LUS score for the hospitalization, were of 85.29%, 44.44%, 85.29% and 76.74% respectively. Conclusions: LUS is an interesting diagnostic tool in the context of Covid-19, it could allow to identify the typical pattern of diffuse interstitial pulmonary syndrome and could guide the correct management of patients.
format Online
Article
Text
id pubmed-10220348
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102203482023-05-28 Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center Granata, Vincenza Fusco, Roberta Villanacci, Alberta Grassi, Francesca Grassi, Roberta Di Stefano, Federica Petrone, Ada Fusco, Nicoletta Ianniello, Stefania Infect Agent Cancer Research Objective: to evaluate the efficacy of US, both qualitatively and semi-quantitatively, in the selection of treatment for the Covid-19 patient, using patient triage as the gold standard. Methods: Patients admitted to the Covid-19 clinic to be treated with monoclonal antibodies (mAb) or retroviral treatment and undergoing lung ultrasound (US) were selected from the radiological data set between December 2021 and May 2022 according to the following inclusion criteria: patients with proven Omicron variant and Delta Covid-19 infection; patients with known Covid-19 vaccination with at least two doses. Lung US (LUS) was performed by experienced radiologists. The presence, location, and distribution of abnormalities, such as B-lines, thickening or ruptures of the pleural line, consolidations, and air bronchograms, were evaluated. The anomalous findings in each scan were classified according to the LUS scoring system. Nonparametric statistical tests were performed. Results: The LUS score median value in the patients with Omicron variant was 1.5 (1–20) while the LUS score median value in the patients with Delta variant was 7 (3–24). A difference statistically significant was observed for LUS score values among the patients with Delta variant between the two US examinations (p value = 0.045 at Kruskal Wallis test). There was a difference in median LUS score values between hospitalized and non-hospitalized patients for both the Omicron and Delta groups (p value = 0.02 on the Kruskal Wallis test). For Delta patients groups the sensitivity, specificity, positive and negative predictive values, considering a value of 14 for LUS score for the hospitalization, were of 85.29%, 44.44%, 85.29% and 76.74% respectively. Conclusions: LUS is an interesting diagnostic tool in the context of Covid-19, it could allow to identify the typical pattern of diffuse interstitial pulmonary syndrome and could guide the correct management of patients. BioMed Central 2023-05-27 /pmc/articles/PMC10220348/ /pubmed/37245026 http://dx.doi.org/10.1186/s13027-023-00515-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Granata, Vincenza
Fusco, Roberta
Villanacci, Alberta
Grassi, Francesca
Grassi, Roberta
Di Stefano, Federica
Petrone, Ada
Fusco, Nicoletta
Ianniello, Stefania
Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title_full Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title_fullStr Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title_full_unstemmed Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title_short Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center
title_sort qualitative and semi-quantitative ultrasound assessment in delta and omicron covid-19 patients: data from high volume reference center
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220348/
https://www.ncbi.nlm.nih.gov/pubmed/37245026
http://dx.doi.org/10.1186/s13027-023-00515-w
work_keys_str_mv AT granatavincenza qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT fuscoroberta qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT villanaccialberta qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT grassifrancesca qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT grassiroberta qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT distefanofederica qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT petroneada qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT fusconicoletta qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter
AT ianniellostefania qualitativeandsemiquantitativeultrasoundassessmentindeltaandomicroncovid19patientsdatafromhighvolumereferencecenter